0002030788-24-000001.txt : 20240730 0002030788-24-000001.hdr.sgml : 20240730 20240730145320 ACCESSION NUMBER: 0002030788-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240730 EFFECTIVENESS DATE: 20240730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brenig Therapeutics, Inc. CENTRAL INDEX KEY: 0002030788 ORGANIZATION NAME: IRS NUMBER: 862552732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-520099 FILM NUMBER: 241156740 BUSINESS ADDRESS: STREET 1: 8 THE GREEN, SUITE 8235 CITY: DOVER STATE: DE ZIP: 19901 BUSINESS PHONE: 818-326-9933 MAIL ADDRESS: STREET 1: 8 THE GREEN, SUITE 8235 CITY: DOVER STATE: DE ZIP: 19901 D 1 primary_doc.xml X0708 D LIVE 0002030788 Brenig Therapeutics, Inc. 8 THE GREEN, SUITE 8235 DOVER DE DELAWARE 19901 818-326-9933 DELAWARE None None Corporation true 2021 Nikolay Savchuk 8 The Green, Suite 8235 Dover DE DELAWARE 19901 Executive Officer Director Iain Dukes 8 The Green, Suite 8235 Dover DE DELAWARE 19901 Executive Officer Director Keno Gutierrez 8 The Green, Suite 8235 Dover DE DELAWARE 19901 Director Edward Mathers 8 The Green, Suite 8235 Dover DE DELAWARE 19901 Director Michele Cucullu 8 The Green, Suite 8235 Dover DE DELAWARE 19901 Director Biotechnology Decline to Disclose 06b false 2024-07-16 false true false 0 65000000 30000000 35000000 The Total Amount Sold includes the conversion of Convertible Promissory Notes with an aggregate principal amount plus accrued interest of approximately $7,837,105. false 6 0 0 0 false Brenig Therapeutics, Inc. /s/Nikolay Savchuk Nikolay Savchuk Chief Executive Officer 2024-07-30